MedTech Dive January 25, 2024
Nick Paul Taylor

The reorganization establishes new divisions at the Office of Strategic Partnerships and Technology Innovation to account for its growth since 2019.

Dive Brief:

  • The Food and Drug Administration has elevated and expanded an office that handles activities including medical device cybersecurity and digital health.
  • Effective immediately, the Office of Strategic Partnerships and Technology Innovation (OST) has become a “super office.” The reorganization creates new divisions and programs at the OST to account for its growth since 2019 and raise the profile of digital health work.
  • The five offices housed in the OST will lead the FDA’s medical device resilient supply chain and shortages program, drive the development of voluntary consensus standards and work on new approaches to digital health...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Cybersecurity, FDA, Govt Agencies, Health IT, Medical Devices, Supply Chain, Technology
Related Articles:
FDA Approves First Biosimilar of Xolair
Opinion: STAT+: How will the Center for Biologics Evaluation and Research change under RFK Jr.?
How the FDA Opens the Door to Risky Chemicals in America’s Food Supply
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

Share This Article